The relationship between FADS1 and gut health is not yet fully established, but plausible mechanisms exist. FADS1 encodes delta-5 desaturase, a key enzyme in polyunsaturated fatty acid (PUFA) metabolism. This enzyme influences the ratio of omega-6 to omega-3 fatty acids, which can modulate inflammatory processes in the gut. An imbalance favoring omega-6 is associated with increased inflammation, relevant to chronic inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis. Some GWAS have linked FADS1 variants to IBD risk, but effect sizes are small and insufficient for individual prediction. Additionally, FADS1 variants may affect gut microbiota composition via altered fatty acid profiles that serve as bacterial substrates. The evidence is primarily mechanistic and based on association studies; randomized controlled trials demonstrating causality are lacking. Therefore, a genetic test for FADS1 cannot reliably assess individual gut health. Results should be viewed as a curiosity, not a medical diagnosis. For gut issues, medical consultation is essential.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-4194dd8ee6ab1e0d4f2db4e5